Compare GPI & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GPI | ELAN |
|---|---|---|
| Founded | 1995 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail-Auto Dealers and Gas Stations | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 10.3B |
| IPO Year | 1997 | 2018 |
| Metric | GPI | ELAN |
|---|---|---|
| Price | $412.50 | $21.28 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 10 |
| Target Price | ★ $478.88 | $22.11 |
| AVG Volume (30 Days) | 182.6K | ★ 4.9M |
| Earning Date | 01-28-2026 | 11-05-2025 |
| Dividend Yield | ★ 0.48% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 28.66 | 0.07 |
| Revenue | ★ $22,537,600,000.00 | $4,591,000,000.00 |
| Revenue This Year | $14.81 | $7.19 |
| Revenue Next Year | $3.33 | $5.32 |
| P/E Ratio | ★ $14.42 | $300.24 |
| Revenue Growth | ★ 19.45 | 3.08 |
| 52 Week Low | $355.91 | $8.02 |
| 52 Week High | $490.09 | $23.70 |
| Indicator | GPI | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 53.20 | 44.60 |
| Support Level | $402.20 | $20.41 |
| Resistance Level | $412.47 | $21.86 |
| Average True Range (ATR) | 10.01 | 0.65 |
| MACD | 3.02 | -0.20 |
| Stochastic Oscillator | 56.37 | 25.38 |
Group 1 owns and operates 39 collision centers and 260 automotive dealerships in the US and the UK, offering 35 brands of automobiles altogether. Slightly over half of the stores are in the US with locations mostly in metropolitan areas in 17 states in the Northeast, Southeast, Midwest, and California. Texas alone contributed 33.5% of new-vehicle unit volume in 2024 and the UK 22.6%. Texas, Massachusetts, and California combined was 48.5%. Revenue in 2024 totaled $19.9 billion. The August 2024 Inchcape UK deal adds about $2.7 billion of annual revenue and 54 stores. The firm entered the UK in 2007 and has 116 stores and about one-third of its new vehicle unit volume there. Group 1 was founded in 1995 and is based in Houston.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.